Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF554 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DCAF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PGRMC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHMP2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDFY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF140 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIMKLA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM267 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TET2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABRACL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL17B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAALC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OVAAL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTNR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRTG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP45 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WFIKKN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on